MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers15225397

Медицинская библиотека · Cancers · 2023

Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.

Tavarozzi Rita, Zacchi Giulia, Pietrasanta Daniela, Catania Gioacchino, Castellino Alessia, Monaco Federico, Gandolfo Carolina, Rivela Paolo, Sofia Antonella, Schiena Noemi, Bertassello Claudia, Limberti Giulia, Zallio Francesco, Zanni Manuela, Ladetto Marco

СтатьяОбзорПеревод пока не подготовлен

Аннотация

We are currently witnessing a dramatic shift in our approach to the treatment of B-cell non-Hodgkin lymphoma (B-NHL). In the evolving clinical landscape, novel treatments for this clinically heterogeneous disease span a wide range of interventions, encompassing targeted agents, cell therapy approaches, and novel monoclonal antibodies (NMABs). Among these, the latter are likely to exert the most profound impact due to their distinctive high efficacy and versatile applicability. NMABs represent a heterogeneous group of agents, including naked antibodies, immunotoxins, and T-cell-engaging molecules. In recent times, several NMABs have either gained regulatory approval or are on the verge of introduction into clinical practice, addressing multiple therapeutic indications and treatment regimens. Their anticipated impact is expected to be broad, initially in the context of relapsed/refractory (R/R) disease and subsequently extending to early treatment lines. The scope of this review is to provide a comprehensive overview of the biological characteristics, clinical properties, efficacy, and toxicity profiles of NMABs that have recently been introduced or are nearing integration into clinical practice.

Для цитирования: Tavarozzi Rita, Zacchi Giulia, Pietrasanta Daniela, Catania Gioacchino, Castellino Alessia, Monaco Federico, Gandolfo Carolina, Rivela Paolo, Sofia Antonella, Schiena Noemi, Bertassello Claudia, Limberti Giulia, Zallio Francesco, Zanni Manuela, Ladetto Marco. Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.. Cancers. 2023. DOI: 10.3390/cancers15225397.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.